PTC治疗学公司的EPS预测降低,而PTC公司尽管有“坚持”评级,但股价却上升。 PTC Therapeutics' EPS forecast was lowered, while PTC Inc.'s stock rose despite a "Hold" rating.

投资公司Cantor Fitzgerald将PTC治疗学的EPS预测值降低到8.20美元, Investment firm Cantor Fitzgerald lowered its FY2025 EPS forecast for PTC Therapeutics to $8.20 but maintains an "Overweight" rating. 同时,软件供应商PTC公司(PTC Inc)的股票持有量被统一投资管理公司减少,Q1 EPS为1.79美元,超过了估计数。 Meanwhile, PTC Inc., a software provider, saw its stock holdings reduced by Unified Investment Management, with Q1 EPS at $1.79, exceeding estimates. PTC的股票在第一季度上涨了3.9%,市场上限为206.7亿美元。 PTC's stock rose 3.9% in the first quarter, with a market cap of $20.67 billion. 分析员将PTC的库存评为“待货”,一致商定价格目标为188.69美元。 Analysts rate PTC's stock as "Hold" with a consensus price target of $188.69.